Industry Research Reports
Home > Reports > Chemical & Material > Global Vitamin K1 Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Vitamin K1 Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 131 Pages
Report ld: 5286112
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Vitamin K1 market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Infants (Under 12 Months) accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Vitamin K1 leading manufacturers including DSM, BUSF, AdvaCare, Innopharma, Suicheng Pharmaceutical, Cheng Yi Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Jiangsu Huayang Pharmaceutical, Brilliant Pharmaceutical, Shandong Guangtongbao Pharmaceuticals, etc., dominate supply; the top five capture approximately % of global revenue, with DSM leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Vitamin K1 market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- DSM
- BUSF
- AdvaCare
- Innopharma
- Suicheng Pharmaceutical
- Cheng Yi Pharmaceutical
- Wuhu Kangqi Pharmaceuticals
- Jiangsu Huayang Pharmaceutical
- Brilliant Pharmaceutical
- Shandong Guangtongbao Pharmaceuticals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injection Fluid
- Tablet
- Others
Segment by Application
- Infants (Under 12 Months)
- Children (1-18 Years Old)
- Adult Male (Over 18 Years Old)
- Adult Female (Over 18 Years Old)
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Vitamin K1 study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Vitamin K1: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Vitamin K1 Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Injection Fluid
1.2.3 Tablet
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Vitamin K1 Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Infants (Under 12 Months)
1.3.3 Children (1-18 Years Old)
1.3.4 Adult Male (Over 18 Years Old)
1.3.5 Adult Female (Over 18 Years Old)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vitamin K1 Revenue Estimates and Forecasts 2020-2031
2.2 Global Vitamin K1 Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Vitamin K1 Sales Estimates and Forecasts 2020-2031
2.4 Global Vitamin K1 Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Vitamin K1 Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Vitamin K1 Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Vitamin K1 Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Injection Fluid Market Size by Manufacturers
4.5.2 Tablet Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Vitamin K1 Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Vitamin K1 Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Vitamin K1 Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Vitamin K1 Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Vitamin K1 Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Vitamin K1 Sales and Revenue by Type (2020-2031)
7.4 North America Vitamin K1 Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Vitamin K1 Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Vitamin K1 Sales and Revenue by Type (2020-2031)
8.4 Europe Vitamin K1 Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Vitamin K1 Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Vitamin K1 Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Vitamin K1 Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Vitamin K1 Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Vitamin K1 Sales and Revenue by Type (2020-2031)
10.4 Central and South America Vitamin K1 Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Vitamin K1 Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Vitamin K1 Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Vitamin K1 Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Vitamin K1 Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 DSM
12.1.1 DSM Corporation Information
12.1.2 DSM Business Overview
12.1.3 DSM Vitamin K1 Product Models, Descriptions and Specifications
12.1.4 DSM Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 DSM Vitamin K1 Sales by Product in 2024
12.1.6 DSM Vitamin K1 Sales by Application in 2024
12.1.7 DSM Vitamin K1 Sales by Geographic Area in 2024
12.1.8 DSM Vitamin K1 SWOT Analysis
12.1.9 DSM Recent Developments
12.2 BUSF
12.2.1 BUSF Corporation Information
12.2.2 BUSF Business Overview
12.2.3 BUSF Vitamin K1 Product Models, Descriptions and Specifications
12.2.4 BUSF Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BUSF Vitamin K1 Sales by Product in 2024
12.2.6 BUSF Vitamin K1 Sales by Application in 2024
12.2.7 BUSF Vitamin K1 Sales by Geographic Area in 2024
12.2.8 BUSF Vitamin K1 SWOT Analysis
12.2.9 BUSF Recent Developments
12.3 AdvaCare
12.3.1 AdvaCare Corporation Information
12.3.2 AdvaCare Business Overview
12.3.3 AdvaCare Vitamin K1 Product Models, Descriptions and Specifications
12.3.4 AdvaCare Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 AdvaCare Vitamin K1 Sales by Product in 2024
12.3.6 AdvaCare Vitamin K1 Sales by Application in 2024
12.3.7 AdvaCare Vitamin K1 Sales by Geographic Area in 2024
12.3.8 AdvaCare Vitamin K1 SWOT Analysis
12.3.9 AdvaCare Recent Developments
12.4 Innopharma
12.4.1 Innopharma Corporation Information
12.4.2 Innopharma Business Overview
12.4.3 Innopharma Vitamin K1 Product Models, Descriptions and Specifications
12.4.4 Innopharma Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Innopharma Vitamin K1 Sales by Product in 2024
12.4.6 Innopharma Vitamin K1 Sales by Application in 2024
12.4.7 Innopharma Vitamin K1 Sales by Geographic Area in 2024
12.4.8 Innopharma Vitamin K1 SWOT Analysis
12.4.9 Innopharma Recent Developments
12.5 Suicheng Pharmaceutical
12.5.1 Suicheng Pharmaceutical Corporation Information
12.5.2 Suicheng Pharmaceutical Business Overview
12.5.3 Suicheng Pharmaceutical Vitamin K1 Product Models, Descriptions and Specifications
12.5.4 Suicheng Pharmaceutical Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Suicheng Pharmaceutical Vitamin K1 Sales by Product in 2024
12.5.6 Suicheng Pharmaceutical Vitamin K1 Sales by Application in 2024
12.5.7 Suicheng Pharmaceutical Vitamin K1 Sales by Geographic Area in 2024
12.5.8 Suicheng Pharmaceutical Vitamin K1 SWOT Analysis
12.5.9 Suicheng Pharmaceutical Recent Developments
12.6 Cheng Yi Pharmaceutical
12.6.1 Cheng Yi Pharmaceutical Corporation Information
12.6.2 Cheng Yi Pharmaceutical Business Overview
12.6.3 Cheng Yi Pharmaceutical Vitamin K1 Product Models, Descriptions and Specifications
12.6.4 Cheng Yi Pharmaceutical Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Cheng Yi Pharmaceutical Recent Developments
12.7 Wuhu Kangqi Pharmaceuticals
12.7.1 Wuhu Kangqi Pharmaceuticals Corporation Information
12.7.2 Wuhu Kangqi Pharmaceuticals Business Overview
12.7.3 Wuhu Kangqi Pharmaceuticals Vitamin K1 Product Models, Descriptions and Specifications
12.7.4 Wuhu Kangqi Pharmaceuticals Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Wuhu Kangqi Pharmaceuticals Recent Developments
12.8 Jiangsu Huayang Pharmaceutical
12.8.1 Jiangsu Huayang Pharmaceutical Corporation Information
12.8.2 Jiangsu Huayang Pharmaceutical Business Overview
12.8.3 Jiangsu Huayang Pharmaceutical Vitamin K1 Product Models, Descriptions and Specifications
12.8.4 Jiangsu Huayang Pharmaceutical Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Jiangsu Huayang Pharmaceutical Recent Developments
12.9 Brilliant Pharmaceutical
12.9.1 Brilliant Pharmaceutical Corporation Information
12.9.2 Brilliant Pharmaceutical Business Overview
12.9.3 Brilliant Pharmaceutical Vitamin K1 Product Models, Descriptions and Specifications
12.9.4 Brilliant Pharmaceutical Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Brilliant Pharmaceutical Recent Developments
12.10 Shandong Guangtongbao Pharmaceuticals
12.10.1 Shandong Guangtongbao Pharmaceuticals Corporation Information
12.10.2 Shandong Guangtongbao Pharmaceuticals Business Overview
12.10.3 Shandong Guangtongbao Pharmaceuticals Vitamin K1 Product Models, Descriptions and Specifications
12.10.4 Shandong Guangtongbao Pharmaceuticals Vitamin K1 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Shandong Guangtongbao Pharmaceuticals Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Vitamin K1 Industry Chain
13.2 Vitamin K1 Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Vitamin K1 Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Vitamin K1 Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Vitamin K1 Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Vitamin K1 Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Vitamin K1 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Vitamin K1 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Vitamin K1 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Vitamin K1 Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Vitamin K1 Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Vitamin K1 Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global Vitamin K1 Sales by Region (2020-2025) & (K MT)
Table 8. Global Vitamin K1 Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Vitamin K1 Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global Vitamin K1 Production by Region (2020-2025) & (K MT)
Table 12. Global Vitamin K1 Production by Region (2026-2031) & (K MT)
Table 13. Global Vitamin K1 Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global Vitamin K1 Sales Share by Manufacturers (2020-2025)
Table 15. Global Vitamin K1 Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Vitamin K1 Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Vitamin K1 by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K1 as of 2024)
Table 19. Global Vitamin K1 Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Vitamin K1 Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Vitamin K1 Manufacturing Base and Headquarters
Table 22. Global Vitamin K1 Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Vitamin K1 Sales by Type (2020-2025) & (K MT)
Table 26. Global Vitamin K1 Sales by Type (2026-2031) & (K MT)
Table 27. Global Vitamin K1 Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Vitamin K1 Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Vitamin K1 ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Vitamin K1 Sales by Application (2020-2025) & (K MT)
Table 32. Global Vitamin K1 Sales by Application (2026-2031) & (K MT)
Table 33. Vitamin K1 High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Vitamin K1 Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Vitamin K1 Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Vitamin K1 ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Vitamin K1 Growth Accelerators and Market Barriers
Table 40. North America Vitamin K1 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Vitamin K1 Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Vitamin K1 Growth Accelerators and Market Barriers
Table 43. Europe Vitamin K1 Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Vitamin K1 Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Vitamin K1 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Vitamin K1 Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Vitamin K1 Growth Accelerators and Market Barriers
Table 48. Southeast Asia Vitamin K1 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Vitamin K1 Investment Opportunities and Key Challenges
Table 50. Central and South America Vitamin K1 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Vitamin K1 Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Vitamin K1 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. DSM Corporation Information
Table 54. DSM Description and Major Businesses
Table 55. DSM Product Models, Descriptions and Specifications
Table 56. DSM Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. DSM Sales Value Proportion by Product in 2024
Table 58. DSM Sales Value Proportion by Application in 2024
Table 59. DSM Sales Value Proportion by Geographic Area in 2024
Table 60. DSM Vitamin K1 SWOT Analysis
Table 61. DSM Recent Developments
Table 62. BUSF Corporation Information
Table 63. BUSF Description and Major Businesses
Table 64. BUSF Product Models, Descriptions and Specifications
Table 65. BUSF Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. BUSF Sales Value Proportion by Product in 2024
Table 67. BUSF Sales Value Proportion by Application in 2024
Table 68. BUSF Sales Value Proportion by Geographic Area in 2024
Table 69. BUSF Vitamin K1 SWOT Analysis
Table 70. BUSF Recent Developments
Table 71. AdvaCare Corporation Information
Table 72. AdvaCare Description and Major Businesses
Table 73. AdvaCare Product Models, Descriptions and Specifications
Table 74. AdvaCare Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. AdvaCare Sales Value Proportion by Product in 2024
Table 76. AdvaCare Sales Value Proportion by Application in 2024
Table 77. AdvaCare Sales Value Proportion by Geographic Area in 2024
Table 78. AdvaCare Vitamin K1 SWOT Analysis
Table 79. AdvaCare Recent Developments
Table 80. Innopharma Corporation Information
Table 81. Innopharma Description and Major Businesses
Table 82. Innopharma Product Models, Descriptions and Specifications
Table 83. Innopharma Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Innopharma Sales Value Proportion by Product in 2024
Table 85. Innopharma Sales Value Proportion by Application in 2024
Table 86. Innopharma Sales Value Proportion by Geographic Area in 2024
Table 87. Innopharma Vitamin K1 SWOT Analysis
Table 88. Innopharma Recent Developments
Table 89. Suicheng Pharmaceutical Corporation Information
Table 90. Suicheng Pharmaceutical Description and Major Businesses
Table 91. Suicheng Pharmaceutical Product Models, Descriptions and Specifications
Table 92. Suicheng Pharmaceutical Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Suicheng Pharmaceutical Sales Value Proportion by Product in 2024
Table 94. Suicheng Pharmaceutical Sales Value Proportion by Application in 2024
Table 95. Suicheng Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 96. Suicheng Pharmaceutical Vitamin K1 SWOT Analysis
Table 97. Suicheng Pharmaceutical Recent Developments
Table 98. Cheng Yi Pharmaceutical Corporation Information
Table 99. Cheng Yi Pharmaceutical Description and Major Businesses
Table 100. Cheng Yi Pharmaceutical Product Models, Descriptions and Specifications
Table 101. Cheng Yi Pharmaceutical Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Cheng Yi Pharmaceutical Recent Developments
Table 103. Wuhu Kangqi Pharmaceuticals Corporation Information
Table 104. Wuhu Kangqi Pharmaceuticals Description and Major Businesses
Table 105. Wuhu Kangqi Pharmaceuticals Product Models, Descriptions and Specifications
Table 106. Wuhu Kangqi Pharmaceuticals Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Wuhu Kangqi Pharmaceuticals Recent Developments
Table 108. Jiangsu Huayang Pharmaceutical Corporation Information
Table 109. Jiangsu Huayang Pharmaceutical Description and Major Businesses
Table 110. Jiangsu Huayang Pharmaceutical Product Models, Descriptions and Specifications
Table 111. Jiangsu Huayang Pharmaceutical Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Jiangsu Huayang Pharmaceutical Recent Developments
Table 113. Brilliant Pharmaceutical Corporation Information
Table 114. Brilliant Pharmaceutical Description and Major Businesses
Table 115. Brilliant Pharmaceutical Product Models, Descriptions and Specifications
Table 116. Brilliant Pharmaceutical Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Brilliant Pharmaceutical Recent Developments
Table 118. Shandong Guangtongbao Pharmaceuticals Corporation Information
Table 119. Shandong Guangtongbao Pharmaceuticals Description and Major Businesses
Table 120. Shandong Guangtongbao Pharmaceuticals Product Models, Descriptions and Specifications
Table 121. Shandong Guangtongbao Pharmaceuticals Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Shandong Guangtongbao Pharmaceuticals Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin K1 Product Picture
Figure 2. Global Vitamin K1 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Injection Fluid Product Picture
Figure 4. Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Vitamin K1 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Infants (Under 12 Months)
Figure 8. Children (1-18 Years Old)
Figure 9. Adult Male (Over 18 Years Old)
Figure 10. Adult Female (Over 18 Years Old)
Figure 11. Others
Figure 12. Vitamin K1 Report Years Considered
Figure 13. Global Vitamin K1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 15. Global Vitamin K1 Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Vitamin K1 Revenue Market Share by Region (2020-2031)
Figure 17. Global Vitamin K1 Sales (2020-2031) & (K MT)
Figure 18. Global Vitamin K1 Sales (CAGR) by Region (2020-2031) (K MT)
Figure 19. Global Vitamin K1 Sales Market Share by Region (2020-2031)
Figure 20. Global Vitamin K1 Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 21. Global Vitamin K1 Production Trend by Region (2020-2031) (K MT)
Figure 22. Global Vitamin K1 Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. Vitamin K1 Production Growth Rate in North America (2020-2031) & (K MT)
Figure 25. Vitamin K1 Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 26. Vitamin K1 Production Growth Rate in China (2020-2031) & (K MT)
Figure 27. Vitamin K1 Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 28. Top 5 and Top 10 Manufacturers Vitamin K1 Sales Volume Market Share in 2024
Figure 29. Global Vitamin K1 Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. Injection Fluid Revenue Market Share by Manufacturer in 2024
Figure 32. Tablet Revenue Market Share by Manufacturer in 2024
Figure 33. Others Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Vitamin K1 Sales Market Share by Type (2020-2031)
Figure 37. Global Vitamin K1 Revenue Market Share by Type (2020-2031)
Figure 38. Global Vitamin K1 Sales Market Share by Application (2020-2031)
Figure 39. Global Vitamin K1 Revenue Market Share by Application (2020-2031)
Figure 40. North America Vitamin K1 Sales YoY (2020-2031) & (K MT)
Figure 41. North America Vitamin K1 Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Vitamin K1 Sales Revenue (US$ Million) in 2024
Figure 43. North America Vitamin K1 Sales Volume (K MT) by Type (2020- 2031)
Figure 44. North America Vitamin K1 Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Vitamin K1 Sales Volume (K MT) by Application (2020-2031)
Figure 46. North America Vitamin K1 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Vitamin K1 Sales YoY (2020-2031) & (K MT)
Figure 51. Europe Vitamin K1 Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Vitamin K1 Sales Revenue (US$ Million) in 2024
Figure 53. Europe Vitamin K1 Sales Volume (K MT) by Type (2020-2031)
Figure 54. Europe Vitamin K1 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Vitamin K1 Sales Volume (K MT) by Application (2020-2031)
Figure 56. Europe Vitamin K1 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 58. France Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Vitamin K1 Sales YoY (2020-2031) & (K MT)
Figure 63. Asia-Pacific Vitamin K1 Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Vitamin K1 Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Vitamin K1 Sales Volume (K MT) by Type (2020- 2031)
Figure 66. Asia-Pacific Vitamin K1 Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Vitamin K1 Sales Volume (K MT) by Application (2020-2031)
Figure 68. Asia-Pacific Vitamin K1 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 73. India Vitamin K1 Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Vitamin K1 Sales YoY (2020-2031) & (K MT)
Figure 75. Central and South America Vitamin K1 Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Vitamin K1 Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Vitamin K1 Sales Volume (K MT) by Type (2021-2031)
Figure 78. Central and South America Vitamin K1 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Vitamin K1 Sales Volume (K MT) by Application (2020-2031)
Figure 80. Central and South America Vitamin K1 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Vitamin K1 Sales YoY (2020-2031) & (K MT)
Figure 84. Middle East and Africa Vitamin K1 Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Vitamin K1 Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Vitamin K1 Sales Volume (K MT) by Type (2021-2031)
Figure 87. South America Vitamin K1 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Vitamin K1 Sales Volume (K MT) by Application (2020-2031)
Figure 89. Middle East and Africa Vitamin K1 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Vitamin K1 Revenue (2020-2025) & (US$ Million)
Figure 94. Vitamin K1 Industry Chain Mapping
Figure 95. Regional Vitamin K1 Manufacturing Base Distribution (%)
Figure 96. Vitamin K1 Production Process
Figure 97. Regional Vitamin K1 Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Vitamin K1 market?
The top companies in the global Vitamin K1 market are DSM、BUSF、AdvaCare.
Related Reports
Vitamin K1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin K1 was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 134
USD 3950.00
(Single User License)
Global Vitamin K1 Market Research Report 2026
The global Vitamin K1 market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 134
USD 2900.00
(Single User License)
Global Vitamin K1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin K1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 76
USD 4250.00
(Single User License)
Global Vitamin K1 Market Research Report 2025
The global market for Vitamin K1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 95
USD 2900.00
(Single User License)
Vitamin K1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin K1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 109
USD 3950.00
(Single User License)
Global Vitamin K1 Market Insights, Forecast to 2030
The global Vitamin K1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 107
USD 4900.00
(Single User License)
Global Vitamin K1 Market Research Report 2024
The global Vitamin K1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-31
Pages: 101
USD 2900.00
(Single User License)
Vitamin K1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin K1 was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 134
USD 3950.00 (Single User License)Global Vitamin K1 Market Research Report 2026
The global Vitamin K1 market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 134
USD 2900.00 (Single User License)Global Vitamin K1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin K1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 76
USD 4250.00 (Single User License)Global Vitamin K1 Market Research Report 2025
The global market for Vitamin K1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 95
USD 2900.00 (Single User License)Vitamin K1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin K1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 109
USD 3950.00 (Single User License)Global Vitamin K1 Market Insights, Forecast to 2030
The global Vitamin K1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 107
USD 4900.00 (Single User License)Global Vitamin K1 Market Research Report 2024
The global Vitamin K1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-31
Pages: 101
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now